In conclusion, PU.1 was related to lymphoma progression through modulating 4-1BB/4-1BBL and PD-1/PD-L1-mediated lymphoma cell interaction with DC, attributing to lenalidomide resistance in FL. The gene discussed is SPI1; the disease is lymphoma.